MXDHF - MDxHealth SA

Other OTC - Other OTC Delayed Price. Currency in USD

MDxHealth SA

CAP Business Center
Rue d'Abhooz, 31
Herstal 4040
Belgium
32 4 364 20 70
http://www.mdxhealth.com

SectorHealthcare
IndustryBiotechnology
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Dr. Jan Groen Ph.D.Chief Exec. Officer, Pres and Exec. Director704.94kN/A1960
Mr. Jean-Marc RoelandtChief Financial Officer and Exec. VPN/AN/A1965
Dr. Wim Van Criekinge Prof., Ph.D.Chief Scientific OfficerN/AN/A1972
Mr. Joseph Sollee J.D., LLMChief Compliance Officer, Exec. VP of Corp. Devel. and Gen. CounselN/AN/A1965
Shalon RothExec. VP of Corp. Communications & Public AffairsN/AN/AN/A
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

MDxHealth SA, a molecular diagnostics company, develops and commercializes epigenetic and other molecular tests for cancer assessment and the personalized treatment of patients in Belgium and internationally. The company's tests are based on genetic, epigenetic (methylation) and other molecular technologies, and assist physicians with the diagnosis of urologic cancers, prognosis of recurrence risk, and prediction of response to a specific therapy. The company's products include ConfirmMDx, a solution for prostate cancer testing; and SelectMDx, a pre-biopsy diagnostic tool for prostate cancer. Its product pipeline includes tests for bladder, kidney, and other urologic cancers. The company was formerly known as OncoMethylome Sciences SA and changed its name to MDxHealth SA in October 2010. MDxHealth SA was founded in 2003 and is headquartered in Herstal, Belgium.

Corporate Governance

MDxHealth SA’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.